Insight Wealth Strategies LLC grew its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 18.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,074 shares of the aerospace company’s stock after purchasing an additional 325 shares during the quarter. Insight Wealth Strategies LLC’s holdings in Leidos were worth $299,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Millennium Management LLC lifted its position in Leidos by 156.5% during the 2nd quarter. Millennium Management LLC now owns 1,133,508 shares of the aerospace company’s stock worth $165,356,000 after acquiring an additional 691,575 shares during the last quarter. FMR LLC increased its stake in shares of Leidos by 27.8% in the third quarter. FMR LLC now owns 2,405,726 shares of the aerospace company’s stock worth $392,133,000 after purchasing an additional 522,764 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Leidos by 13.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company’s stock worth $571,216,000 after purchasing an additional 405,256 shares during the last quarter. International Assets Investment Management LLC boosted its stake in Leidos by 24,194.3% during the 3rd quarter. International Assets Investment Management LLC now owns 377,047 shares of the aerospace company’s stock valued at $61,459,000 after purchasing an additional 375,495 shares during the period. Finally, AQR Capital Management LLC grew its holdings in Leidos by 76.9% in the 2nd quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock valued at $101,942,000 after buying an additional 303,775 shares during the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.
Insider Transactions at Leidos
In related news, Director Noel B. Geer purchased 2,000 shares of Leidos stock in a transaction that occurred on Wednesday, November 20th. The shares were acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $322,260. This represents a ? increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $184.94, for a total transaction of $193,632.18. Following the completion of the sale, the director now owns 6,408 shares of the company’s stock, valued at $1,185,095.52. The trade was a 14.04 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is owned by company insiders.
Leidos Price Performance
Leidos (NYSE:LDOS – Get Free Report) last issued its earnings results on Tuesday, October 29th. The aerospace company reported $2.93 EPS for the quarter, beating the consensus estimate of $1.96 by $0.97. Leidos had a net margin of 7.37% and a return on equity of 30.31%. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.06 billion. During the same quarter in the previous year, the company earned $2.03 EPS. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year. On average, analysts expect that Leidos Holdings, Inc. will post 9.89 earnings per share for the current fiscal year.
Leidos Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 31st. Stockholders of record on Monday, December 16th were paid a $0.40 dividend. The ex-dividend date was Monday, December 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.08%. This is a boost from Leidos’s previous quarterly dividend of $0.38. Leidos’s payout ratio is 18.22%.
Analyst Ratings Changes
A number of brokerages have recently commented on LDOS. Barclays upped their price target on Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a report on Monday, November 4th. UBS Group initiated coverage on shares of Leidos in a research note on Monday, December 2nd. They set a “neutral” rating and a $182.00 target price for the company. Truist Financial decreased their price target on shares of Leidos from $205.00 to $185.00 and set a “buy” rating on the stock in a research report on Friday, November 22nd. Wells Fargo & Company cut their price objective on shares of Leidos from $230.00 to $205.00 and set an “overweight” rating for the company in a research report on Tuesday, November 26th. Finally, Citigroup lifted their target price on Leidos from $194.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $182.00.
Read Our Latest Stock Report on Leidos
About Leidos
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Recommended Stories
- Five stocks we like better than Leidos
- Best Stocks Under $5.00
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding LDOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Leidos Holdings, Inc. (NYSE:LDOS – Free Report).
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.